What to Expect in the First Week of GLP‑1 Therapy

Learn the typical symptoms, appetite changes, and early weight loss you may notice during week one of GLP‑1 treatment.

What to Expect in the First Week of GLP‑1 Therapy

GLP‑1 receptor agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound have become popular tools for managing type 2 diabetes and supporting weight loss. While many patients focus on the long‑term outcomes, the first week often sets the tone for how the medication will feel in the weeks to come. Understanding the early effects helps you stay confident, anticipate common symptoms, and make informed adjustments.

Typical Symptoms During the First Seven Days

When you start a GLP‑1 medication, you are essentially introducing a hormone that mimics the body’s own glucagon‑like peptide‑1. This triggers a cascade of physiological responses that most people notice within the first few days. Below are the most common experiences:

  • Nausea or mild stomach upset – Often described as a queasy feeling after meals. It typically peaks 2–3 days after the first dose and wanes by day 5–7.
  • Reduced appetite – A natural consequence of slowed gastric emptying; you may feel full after a smaller portion.
  • Changes in bowel habits – Some users report occasional constipation or, less frequently, loose stools.
  • Headache or mild fatigue – These can be linked to fluid shifts or the body adjusting to new glucose regulation.
  • Injection site reactions – A small amount of redness or tenderness at the injection site is normal and usually resolves quickly.

These symptoms are generally mild to moderate and are considered part of the early effects of GLP‑1 therapy. They rarely require medical intervention, but staying hydrated and eating balanced meals can help mitigate discomfort.

Appetite Changes: Why You Might Feel Fuller Sooner

One of the hallmark early benefits of GLP‑1 agonists is a pronounced appetite reduction. The medication works by:

  1. Slowing gastric emptying, which prolongs the feeling of fullness after eating.
  2. Activating GLP‑1 receptors in the brain’s appetite‑control centers, decreasing hunger signals.

During the first week, many patients notice they can stop eating after a smaller portion, especially with high‑carbohydrate meals. This can be a useful tool for establishing new eating patterns, but it may also feel unsettling if you’re accustomed to larger meals. To manage this transition:

  • Focus on nutrient‑dense foods – Choose vegetables, lean proteins, and healthy fats that provide satiety without excess calories.
  • Eat mindfully – Slow down, chew thoroughly, and pause between bites to gauge true hunger.
  • Plan smaller, frequent meals – This can help sustain energy levels while your stomach adjusts.

Early Weight Loss: What the Numbers Might Look Like

Weight loss during the first week of GLP‑1 therapy is often modest but perceptible. Most clinicians report an approximate loss of 1–2 pounds (0.5–1 kg) in the initial seven days, primarily due to reduced calorie intake and water loss. Because individual responses vary, it’s important to track trends rather than focus on a single data point.

Key points to remember:

  • Fluid shifts – Initial weight loss may include water weight; this stabilizes after the first two weeks.
  • Caloric deficit – The reduced appetite typically leads to a lower daily calorie intake, which drives gradual fat loss.
  • Consistency matters – Maintaining the medication schedule and adhering to a balanced diet maximizes long‑term results.

Managing Common Side Effects

While most side effects are mild, you can take proactive steps to feel more comfortable during the first week:

  • Hydration – Aim for at least 8 cups of water daily to help with nausea and constipation.
  • Gentle foods – Opt for broth‑based soups, plain oatmeal, or steamed vegetables if you feel queasy.
  • Gradual dose escalation – Some providers start with a lower dose and increase after a few days to reduce gastrointestinal upset.
  • Movement – Light walking or stretching can aid digestion and improve mood.

If any symptom becomes severe (e.g., persistent vomiting, severe abdominal pain, or signs of allergic reaction), contact your healthcare provider promptly.

What to Track in Your First Week Journal

Keeping a simple journal can help you and your clinician fine‑tune the therapy. Record the following each day:

  1. Time of injection and dose amount.
  2. Meals consumed, portion sizes, and any cravings.
  3. Any side effects experienced, including severity (mild, moderate, severe).
  4. Weight measurement (optional, but useful for trend analysis).

Reviewing this log after the first week will provide clear insights into how your body is responding and where adjustments may be needed.

Frequently Asked Questions

Will I feel the effects of GLP‑1 immediately?

Most users notice a reduction in appetite and mild gastrointestinal symptoms within the first 24–48 hours. Significant weight loss typically becomes evident after the first week.

Can I combine GLP‑1 therapy with other weight‑loss medications?

Combination therapy should only be pursued under direct medical supervision. Some medications may interact or increase side‑effect risk, so a clinician’s guidance is essential.

Is it safe to exercise while experiencing nausea?

Light to moderate activity, such as walking or gentle yoga, is generally safe and may actually help reduce nausea. However, if you feel dizzy or excessively fatigued, pause the workout and rest.

How long does the nausea usually last?

For most patients, nausea peaks around day 2–3 and improves by day 5–7. Extending the dose‑escalation period or adjusting meal composition can further diminish this symptom.

Getting Started with GLP‑1

Embarking on GLP‑1 therapy involves a few essential steps to ensure safety and effectiveness:

  • Consult a qualified healthcare professional – A physician or licensed practitioner will assess your medical history, current medications, and eligibility for GLP‑1 treatment.
  • Choose the right formulation – Options such as Ozempic, Wegovy, Mounjaro, and Zepbound differ in dosing frequency and approved indications.
  • Understand the administration technique – Most GLP‑1 agents are injected subcutaneously; your provider will demonstrate proper technique.
  • Set realistic expectations – Early weight loss is modest, and side effects are usually temporary.

For many, the convenience of a licensed online provider offers a streamlined way to begin therapy without unnecessary delays. If you’re curious about whether GLP‑1 is right for you, you can check your eligibility here.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any medication regimen. Individual results may vary, and the information provided should not replace personalized medical guidance.